1、HCV Market Intelligence Report 2021 and Preliminary HBV Market Insights Clinton Health Access Initiative,Inc.(CHAI)2021Photography by:Soksamphoas Im,Christine McNab,Melinda StanleyDisclaimer:The data sources primarily used for analysis in the report include the India Import Export data,CHAI country

2、teams,Ministry of Health counterparts,stakeholder(WHO,MPP,and NGO and civil society partners,such as FIND,TAG,World Hepatitis Alliance,etc.)conversations,and regulatory information provided by drug suppliers.CHAI has taken precautions to verify the information shared on the report.However,the analys

3、is in the report is not exhaustive,and the responsibility for the interpretation and use of the material lies with the reader.The mention of specific companies or supplier products does not imply that CHAI is endorsing or recommending them.ContentsAcknowledgments.1Acronyms.2Executive summary.4Introd

4、uction.7COVID-19 impact and potential opportunities.7WHO-recommended HCV testing and treatment guidance updates .9HCV landscapes and trends.11HCV diagnostics.11Supplier landscape.12Pricing and cost considerations of screening and liver staging.14HCV viral load cost considerations .16HCV treatment.23

5、Supplier landscape.23Volume trends.25Pricing trends.27Retreatment market trends.30Pediatric HCV treatment.31Looking forward.33Preliminary information on the HBV market.35Introduction.35WHO-recommended HBV testing and treatment guidelines.36HBV diagnostic market trends.38HBV treatment market trends.4

6、0HBV birth dose vaccine market trends.41HBV markets on the horizon.41Glossary.42Appendix .43HCV Market Intelligence Report 2021 and Preliminary HBV Market Insights|1AcknowledgmentsThis publication was developed by the Clinton Health Access Initiative(CHAI).The shipment data obtained from the India i